¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"linear IgA dermatitis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® linear accelerator ÇÑ±Û ¼±»ó°¡¼Ó±â
¼³¸í   
  Ä¡·á¹æ»ç¼±°ú¿¡¼­ ÀÌ¿ëÇϴ ±â°è·Î¼­ ÀüÀÚ¸¦ »ý¼ºÇØ ³½´Ù. ÀüÀڴ ´Ü¼øÈ÷ X-¼±°ú´Â ´Ù¸¥ °ÍÀ¸·Î ÀüÀÚ°¡ ±Ý¼Ó¿¡ ºÎµúÇô ³ª¿À´Â °ÍÀÌ X-¼±ÀÌ´Ù. ÀüÀڴ Áø´Ü¸ñÀûº¸´Ù´Â Ä¡·á¸ñÀûÀ¸·Î ÁַΠÇǺÎÀÇ ¾Ç¼ºÁ¾¾ç(¾Ï)¿¡ »ç¿ëµÈ´Ù.
¿µ¹® seborrheic dermatitis ÇÑ±Û Áö·çÇǺο°
¼³¸í   
  ÇǺÎÀÇ ¸¸¼º¿°ÁõÀ¸·Î ¸Ó¸®µ¤°³, ¾ó±¼(´«½ç, ÀÔ¼ú, ´«²¨Ç°, ±Í µî), º¹Àå»ÀºÎÀ§, °Üµå¶ûÀÌ µî¿¡ È£¹ßÇϴ ÇǺκ´ÀÌ´Ù. ÀÌ º´Àº ¸¶¸£°Å³ª ½À±â°¡ Àְųª, ±â¸§±â°¡ Àִ ºñ´ÃÀ̠Ư¡À̰í, ´Ù¾çÇÑ ¸ð¾ç°ú Å©±âÀǠȲ»ö¹ÝÀ» Çü¼ºÇϸç È£Àü°ú ¾ÇÈ­¸¦ µÇÇ®ÀÌ Çϰí, ´Ù¼Ò °¡·Á¿î °¨°¢À» µ¿¹ÝÇÑ´Ù.
¿µ¹® dermatitis ÇÑ±Û ÇǺο°
¼³¸í   
  ÇǺο°À̶ó°í Çϸé À̰ÍÀº ½ÀÁøÇǺκ´(eczematous dermatoses)À» À̸£´Â ¸»ÀÌ´Ù. ½ÀÁøÀ̶õ ±Þ¼º±â¿¡´Â °¡·Á¿òÁõÀ» µ¿¹ÝÇϴ ¼öÆ÷³ª, È«¹Ý, ºÎÁ¾ µîÀÌ ³ªÅ¸³ª°í ¸¸¼º±â¿¡´Â ºÎÁ¾, ¼öÆ÷´Â °¨¼ÒµÇ´Â ¹Ý¸é¿¡ Å¼±È­, ºñ´Ã, ÇǺλöÀÇ º¯È­ µîÀÌ Çü¼ºµÇ´Â ¸ðµç ÇǺκ´µéÀ» À̸£´Â ¸»ÀÌ´Ù. ±× ¹ß»ýºóµµ´Â Áö¿ª¿¡ µû¶ó ´Ù¼Ò Â÷À̰¡ ÀÖÀ¸³ª Àüü ÇǺÎÁúȯÀÇ ¾à 1/3~1/4À» Â÷ÁöÇϰí ÀÖ´Ù.
  
  1.Á¢ÃËÇǺο°(contact dermatitis)-¿ÜºÎ¹°ÁúÀÇ Á¢ÃË¿¡ ÀÇÇØ¼­ ¹ß»ýÇϴ ÇǺο°À» ¸»ÇÑ´Ù. ¹°À̳ª ¼¼Á¦¿¡ Àå±âÀû Á¢ÃË¿¡ ÀÇÇØ¼­ ¼Õ³¡ºÎÀ§¿¡ »ý±â´Â ÁֺνÀÁø(housewife's eczema)À̳ª °øÀå¿¡¼­ À¯µ¶ÇÑ ¹°ÁúÀÇ Á¢ÃË¿¡ ÀÇÇØ¼­ »ý±â´Â ÇǺο° µîÀÌ À̰ÍÀÇ ¿¹ÀÌ´Ù.
  
  2.¾ÆÅäÇÇÇǺο°(atopic dermatitis)-ÇǺΰ¡ °¡·Á¿ò¿¡ ´ëÇÑ ¿ªÄ¡°¡ ³·¾Æ¼­ ¾ÆÁÖ ½ÉÇÑ °¡·Á¿òÀ» ´À³¢°í À̷ΠÀÎÇØ¼­ 2Â÷ÀûÀ¸·Î »ý±â´Â ½ÀÁøÀ¸·Î À¯ÀüÀûÀΠ°æÇâÀÌ ¾ÆÁÖ °­ÇÏ´Ù. ¾ÆÁÖ ½ÉÇÑ °¡·Á¿òÁõ°ú Æ¯Á¤ÇÑ ¹ßº´ºÎÀ§·Î ´ë°³ Áø´ÜÀÌ µÇ´Âµ¥ 2¼¼ÀÌÇÏÀÇ À¯¾Æ¿¡°Ô »ý°åÀ» °æ¿ì¿¡´Â ÁַΠ»´, À̸¶, µÎÇÇ µîÀÇ ¾ó±¼¿¡ ¸¹ÀÌ »ý±â°í, ¼Ò¾Æ±âÀÇ °æ¿ì¿¡´Â ÁַΠ¹«¸­À̳ª ÆÈ²ÞÄ¡ÀÇ »ìÀÌ Á¢È÷´Â ºÎÀ§¿¡ ¸¹ÀÌ »ý±ä´Ù. 1¼¼ ¹Ì¸¸ÀÇ À¯¾Æ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇϸç, ³ªÀ̰¡ µé¼ö·Ï È£ÀüµÇ´Â °æ°ú¸¦ º¸ÀδÙ.
  
  3.Áö·ç ÇǺο°(seborrheic dermatitis)-¸¸¼ºÀÇ °æ°ú¸¦ ÃëÇϴ ½ÀÁøÀÇ ÀÏÁ¾À¸·Î ÁַΠÇÇÁöÀÇ ºÐºñ°¡ ¿Õ¼ºÇÑ ºÎÀ§(¸Ó¸®µ¤°³, ¾ó±¼, °¡½¿ µîÀÇ Áß°£ ºÎÀ§)¿¡ ³ë¶õ»ö ³»Áö ºÓÀº»öÀÇ ¸¸¼º ½ÀÁøÀÇ ¾ç»óÀ» ³ªÅ¸³»´Â º´º¯, Æ¯È÷ ¹øµé¹øµéÇÑ ºñ´ÃÀ̠Ư¡ÀûÀ¸·Î Çϴ º´º¯À» Á֠Ư¡À¸·Î Çϴ ÁúȯÀÌ´Ù. ¿øÀÎÀº È®½ÇÇÏÁö ¾ÊÀ¸³ª Pityrosporum ovaleÀ̶ó´Â ±Õ°ú °¡Á··Â, ½Å°æº´°ú ¿¬°üÀÌ ÀÖ´Ù°í ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • IgA nephropathy
    IgAÄáÆÏº´(Áõ), IgA½ÅÀ庴(Áõ)
  • general linear model
    ÀϹݼ±Çü¸ðµ¨
  • linear
    ÁÙ(¸ð¾ç)-, ¼±Çü-, ¼±»ó-
  • linear acceleration
    ¼±Çü°¡¼Óµµ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear attenuation coefficient
    ¼±Çü°¨¼è°è¼ö
  • linear correlation
    ¼±Çü»ó°ü
  • linear density
    ¼±À½¿µ
  • linear electronic scanner
    ¼±ÀüÀڽĽºÄ³³Ê
  • linear fracture
    ¼±°ñÀý, ¼±»ó°ñÀý
  • linear molecule
    ¼±ÇüºÐÀÚ
  • linear nevus
    ¼±¸ð¹Ý
  • linear perspective
    ¼±»óÅõ½Ã
  • linear phased array
    ¼±ÇüÀ§»óÂ÷¹è¿­, ÁÙÀ§»óÂ÷¹è¿­
  • linear regression
    ¼±Çüȸ±Í
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • IgA nephropathy
    ¸é¿ª±Û·Îºí¸°¿¡ÀÌÄáÆÏº´Áõ, ¸é¿ª±Û·Îºí¸°¿¡À̽ÅÀ庴Áõ
  • linear acceleration
    ¼±Çü°¡¼Ó
  • linear fracture
    ¼±°ñÀý
  • linear regression
    ¼±Çüȸ±Í
  • dermatitis
    ÇǺο°
  • allergic contact dermatitis
    ¾Ë·¹¸£±âÁ¢ÃËÇǺο°
  • atopic dermatitis
    ¾ÆÅäÇÇÇǺο°
  • photoallergic contact dermatitis
    ±¤¾Ë·¹¸£±âÁ¢ÃËÇǺο°
  • primary irritant dermatitis
    ¿ø¹ßÀÚ±ØÇǺο°
  • stasis dermatitis
    Á¤Ã¼ÇǺο°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • linear acceleration
    ¼±Çü°¡¼Ó
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear phased array
    ÁÙÀ§»óÂ÷¹è¿­
  • linear sequenced array
    ÁÙ¸ð¾ç¼ø¼­¹è¿­, ¼±Çü¼øÂ÷¹è¿­
  • linear switched array
    ÁÙ±³´ë½Ä¹è¿­
  • linear correlation
    ¼±»ó»ó°ü
  • linear attenuation coefficient
    ¼±Çü°¨¼è°è¼ö
  • linear type constitution
    ¼±ÇüüÇü
  • linear density
    ¼±À½¿µ
  • linear lichenoid dermatosis
    ¼±»óż±¸ð¾çÇǺκ´
  • linear equation
    ÀÏÂ÷¹æÁ¤½Ä
  • linear fracture
    ¼±»ó°ñÀý
  • linear skull fracture
    ¼±»ó¸Ó¸®°ñÀý, µÎ°³°ñ¼±»ó°ñÀý
  • general linear model
    ÀϹݼ±»ó¸ðµ¨
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • IgA, secretory
    ºÐºñÇü IgA
  • anti-IgA
    Ç× IgA Ç×ü
  • iga deficiency
    ¸é¿ª±Û·ÎºÒ¸° A °áÇÌ
  • iga nephroathy
    ¸é¿ª±Û·ÎºÒ¸° A ½Åº´Áõ
  • immunoglobulin a(iga)
    ¸é¿ª±Û·ÎºÒ¸° A(Øó湡­)
  • Linear acceleration
    ¼±»ó°¡¼Ó(àÊ߾ʥáÜ)
  • arrays, linear sequenced
    ¼±Çü ¼øÂ÷ ¹è¿­ (àÊû¡ â÷ó­ ÛÉæê)
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • phased linear array type
    À§»óÂ÷ ¼±Çü ¹è¿­½Ä
  • phased linear array type
    À§»óÂ÷ ¹è¿­½Ä ¼±Çü (êÈßÓó¬ ÛÕÖªãÒ àÊû¡) Æ®·£½ºµà¼­
  • radiation,linear energy transfer (let)
    ¼±»ó¿¡³ÊÁöÀüȯ(àÊß¾¡­ï®üµ)
  • Dermatitis
    ÇǺο°
  • Duhrings disease => dermatitis herpetiformis
    Æ÷Áø»ó ÇǺο°
  • actinic dermatitis
    ±¤¼±ÇǺο°
  • acute dermatitis
    ±Þ¼º(Ðáàõ) ÇǺο°(ù«Ý±æú)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • linear IgA dermatitis
    ¼±»ó ¸é¿ª±Û·ÎºÒ¸°A ÇǺο°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bullous dermatosis,linear iga
    ¼±»ó IgA (àÊß¾¡­)
  • linear IgA bullous dematosis
    ¼±»ó ¸é¿ª±Û·ÎºÒ¸°A ¼öÆ÷¼ºÇǺκ´
  • linear IgA dermatosis
    ¼±»ó ¸é¿ª±Û·ÎºÒ¸°A ÇǺκ´(Áõ)
  • dermatitis factitia = factitial dermatitis
    Àΰø ÇǺο°
  • dermatitis vegetans = dermatitis vegetativa
    Áõ½Ä¼º ÇǺο°
  • hypostatic dermatitis => stasis dermatitis
  • anti-IgA
    Ç× IgA Ç×ü
  • iga deficiency
    ¸é¿ª±Û·ÎºÒ¸° A °áÇÌ
  • iga nephroathy
    ¸é¿ª±Û·ÎºÒ¸° A ½Åº´Áõ
  • immunoglobulin a(iga)
    ¸é¿ª±Û·ÎºÒ¸° A(Øó湡­)
  • intra-epidermal neutrophilic IgA dermatosis
    Ç¥Çdz»È£Áß±¸¼º ¸é¿ª±Û·ÎºÒ¸°A ÇǺκ´
  • isolated iga deficiency
    ´Üµ¶¼º¸é¿ª±Û·ÎºÒ¸°A°áÇÌ(Ó¤Ô¼àõ Øóæ¹ ¡­ ÌÀù¹)
  • secretory IgA
    ºÐºñÇü IgA.
  • arrays, linear sequenced
    ¼±Çü ¼øÂ÷ ¹è¿­ (àÊû¡ â÷ó­ ÛÉæê)
  • fine horizontal linear opacity
    ¹Ì¼¼ÇÑ ¼öÆò¸éÇü ¼±»ó ºÒÅõ¸íü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • caterpillar dermatitis
    ¸ðÃæÇǺο°
  • insect dermatitis
    °ïÃæÇǺο°
  • schistosome dermatitis
    ÁÖÇ÷ÈíÃæÇǺο°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • IgA
    (å²) immunoglobulin A
  • linear absorption coefficient
    ¼±Èí¼ö°è¼ö(àÊýåâ¥Ìõâ¦)
  • linear accelerator
    ¼±Çü°¡¼Ó±â(àÊû¡Ê¥áÜѦ)
  • linear chain
    ¼±Çü(àÊû¡)»ç½½
  • linear correlation
    ¼±Çü »ó°ü(àÊû¡ßÓμ)
  • linear density gradient
    ¼± ¹Ðµµ(à»ÚËÓø)±â¿ï±â
  • linear dichroism
    ¼±Çü ÀÌ»ö¼º(àÊû¡ì£ßäàõ)
  • linear electric field effect
    ¼±Çü Àü±âÀåÈ¿°ú(àÊû¡ï³Ñ¨íÞüùÍý)
  • linear energy transfer
    ¼±Çü(àÊû¡) ¿¡³ÊÁöÀüÀÌ(ï®ì¹)
  • linear growth
    ¼±Çü¼ºÀå(àÊû¡à÷íþ)
  • linear inhibition
    ¼±ÇüÀúÇØ(àÊû¡îÁúª)
  • linear metabolic pathway
    ¼±Çü ´ë»ç°æ·Î(àÊû¡ÓÛÞóÌèÖØ)
  • linear polymer
    ¼±ÇüÁßÇÕü(àÊû¡ñìùêô÷)
  • linear polyphosphate
    ¼±ÇüÁßÀλê(àÊû¡ñììÝß«)
  • linear regression
    ¼±Çüȸ±Í(àÊû¡üÞÏý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • contact dermatitis
    Á¢ÃËÇǺο°
  • dermatitis
    ÇǺο°
  • radiation dermatitis
    ¹æ»ç¼±ÇǺο°
  • stasis dermatitis
    ¿ïÇ÷¼ºÇǺο°
  • digital linear tape(DLT)
    µðÁöÅÐ Å×ÀÌÇÁ ÀúÀåÀåÄ¡
  • fine horizontal linear opacity
    ¹Ì¼¼ÇÑ ¼öÆò¸éÇü ¼±»ó ºÒÅõ¸íü
  • general linear model
    ÀϹÝÀû ¼±Çü¸ðµ¨, ÀÏ¹Ý ¼±»ó¸ðµ¨
  • linear
    ¼±»ó, ¼±Çü
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear array
    ¼±Çü ¹è¿­
  • linear correlation
    ¼±»ó»ó°ü
  • linear density
    ¼±»óÀ½¿µ
  • linear electronic scanner
    ¼±ÇüÀüÀڽĽºÄ³³Ê
  • linear fracture
    ¼±»ó°ñÀý
  • linear interpolation algorithm(LIA)
    ¼±»óº¸°£¿¬»ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Ig Immuno-globulin
  IgA; Immuno-globulin A; (27)(30)60(100) - (170)(80)(250)380 mg/dL
IGA infantile genetic agranulocytosis
IgA immunoglobulin A
S-IgA secretory immunoglobulin A
ACD   1) Absolute Cardiac Dullness; Àý´ë½ÉµÐŹÀ½
  2) Anemia of Chronic Disease
&nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IgA-D IgA deficiency
IgA GN IgA glomerulonephritis
IgA-IC IgA immune complex
IgA NP IgA nephropathy
IgA RF IgA rheumatoid factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • linear IgA disease
    ¼±»ó ¸é¿ª ±Û·ÎºÒ¸° A Áúȯ
  • iga nephroathy
    ¸é¿ª ±Û·ÎºÒ¸° A ½Åº´Áõ
  • secretory IgA
    ºÐºñÇü ¸é¿ª ±Û·ÎºÎ¸° A
    Ç÷û, Ÿ¾×, ´«¹°, È£Èí±â, ¼ÒÈ­°ü µîÀÇ ºÐºñ¾× Áß ÇÔÀ¯µÇ¾î ÀÖ´Ù.
  • coefficient of linear thermal expansion
    ¿­ ÆØÃ¢ °è¼ö
    ¹°Ã¼ÀÇ ¿Âµµ¸¦ 1µµ »ó½Â½ÃÅ´¿¡ µû¸¥ ±æÀÌÀÇ Áõ°¡À².
  • fine horizontal linear opacity
    ¹Ì¼¼ÇÑ ¼öÆò¸éÇü ¼±»ó ºÒÅõ¸íü
  • linear
    ¼±»ó, ¼±Çü, ¼±»óÀÇ
    ¼±¿¡ ¼ÓÇϰųª ¼±°ú ´àÀº.
  • linear coefficient of expansion
    ¼± ÆØÃ¢ °è¼ö
    °íüÀÇ ¿­ ÆØÃ¢¿¡ µû¸¥ ±æÀÌÀÇ º¯È­ ºñÀ². 0 ¡É¿¡¼­ ±æÀÌ lÀÎ ¹°Ã¼°¡ ¿Âµµ º¯È­ d¿¡ ´ëÇØ dl¸¸Å­ ¿­ ÆØÃ¢ÇÒ ¶§,
  • linear coefficient of thermal expansion
    ¼± ¿­ ÆØÃ¢ °è¼ö
  • linear energy transfer
    ¼± ¿¡³ÊÁö ºÎ¿©
  • linear expansion
    ¼± ÆØÃ¢
    ¹°Ã¼ÀÇ ±æÀ̰¡ ´Ã¾î³ª´Â °Í. ƯÈ÷ ¹°Ã¼°¡ ÀÏÁ¤ ¾Ð·ÂÇÏ¿¡¼­ ¿ÂµµÀÇ º¯È­¿¡ µû¶ó Å©±â¸¦ º¯È­½ÃŰ´Â °ÍÀ» ¿­ ÆØÃ¢À̶ó°í ÇÑ´Ù.
  • linear lichen planus
    ¼±»ó ÆíÆò ż±
  • linear nevus sebaceous syndrome
    ¼±»ó ¸ð¹Ý ÇÇÁö¼± ÁõÈıº
  • linear optical characteristics
    ¼±Çü ±¤ÇРƯ¼º
  • linear polymer
    ¼±»ó ÁßÇÕü
    ºÐÀÚÀÇ Çü»óÀÌ »ç»óÀÎ ÁßÇÕ¹°·Î ºÐÁöÇÑ ÁßÇÕ¹°, ȤÀº °¡°øµÈ ÁßÇÕ¹°¿¡ ´ëºñµÈ´Ù´Â ¶æ.
  • linear shadow
    ¼±»ó À½¿µ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
linear IgA bullous disease in children A rare self-limiting bullous disease, chiefly of the trunk, perioral, and pelvic areas, with onset in the first decade, successively less severe recurrences, and total remission at adolescence; linear epidermal basement membrane zone deposit of IgA is found in involved and in normal skin.
Synonym: linear IgA bullous disease in children.
(05 Mar 2000)
glomerulonephritis, IgA Chronic form of glomerulonephritis characterised by recurring haematuria with only slight proteinuria and by deposits of IgA immunoglobulin in the mesangial areas of the renal glomeruli. It usually occurs in young males.
(12 Dec 1998)
secretory component of IgA <immunology, protein> A polypeptide chain of about 60 kD that aids secretion of the IgA, a portion of the IgA receptor on the plasmalemma of the inner side of the epithelial cells lining the gut, which is proteolysed when the IgA receptor complex has travelled through the cell after receptor mediated endocytosis at the inner face, to the outer (luminal) face.
(18 Nov 1997)
IgA <immunology> Major class of immunoglobulin of external secretions in mammals, also found in serum and body fluids such as tears and saliva and in the respiratory, reproductive, urinary and gastrointestinal tracts.
Immunoglobulin A protects the bodys mucosal surfaces from infection and in secretions, it is found as a dimer (400 kD) joined by a short J chain and linked to a secretory portion or transport piece. In serum found as a monomer (170 kD).
Immunoglobulin A is the main mechanism for providing local immunity against infections in the gut or respiratory tract and may act by reducing the binding between an immunoglobulin A coated micro organism and a host epithelial cell. Present in human colostrum but not transferred across the placenta. Have heavy chains.
(30 Mar 1998)
IgA deficiency A dysgammaglobulinaemia characterised by a deficiency of IgA.
(12 Dec 1998)
IgA nephropathy <nephrology, pathology> This is a form of glomerulonephritis that results from the deposition of circulating IgA antibody in the kidney tissues.
Inflammation of the glomerulus (glomerulonephritis) is the result. This condition may present as acute glomerulonephritis, chronic glomerulonephritis or rapidly progressive glomerulonephritis.
Berger's is usually detected in an individual with one or two bouts of bloody urine (usually begins during or soon after a respiratory infection) and no other symptoms of renal disease. Only rarely, will Berger's disease permanently affect kidney function and progress to chronic renal failure. This renal disorder more commonly affects males in the 16-40 age group.
Origin: Gr. Pathos = disease
(27 Sep 1997)
IgA, secretory The principle ig found in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. It is composed of two to four molecules of 7s IgA and one molecule each of j chain and secretory component (sc), also called secretory piece. Molecular weight appr. 400,000.
(12 Dec 1998)
IgA-specific serine endopeptidase <enzyme> Extracellular microbial enzymes whose only substrate is human IgA of the iga1 subclass; cleave the immunoglobulin at a specific internal prolyl-threonyl peptide bond in the heavy chain to yield intact faba and fca fragments; consider also EC 3.4.24.13
Registry number: EC 3.4.21.72
Synonym: immunoglobulin a(1) protease, iga1 protease, immunoglobulin a1 protease, IgA protease
(26 Jun 1999)
programming, linear A technique of operations research for solving certain kinds of problems involving many variables where a best value or set of best values is to be found. It is most likely to be feasible when the quantity to be optimised, sometimes called the objective function, can be stated as a mathematical expression in terms of the various activities within the system, and when this expression is simply proportional to the measure of the activities, i.e., is linear, and when all the restrictions are also linear. It is different from computer programming, although problems using linear programming techniques may be programmed on a computer.
(12 Dec 1998)
non-linear Not linear.
(05 Dec 1998)
superficial linear keratitis Spontaneous, painful keratitis with epithelial erosion and folds in Bowman's membrane.
(05 Mar 2000)
linear Pertaining to or resembling a line.
Origin: L. Linearis
(18 Nov 1997)
linear absorption coefficient That fraction of ionizing radiation absorbed in a unit thickness of a substance or tissue.
See: absorption coefficient.
(05 Mar 2000)
linear acceleration The rate of change of velocity without a change in direction; e.g., when the speed of an aircraft increases while flying a straight pathway.
(05 Mar 2000)
linear accelerator <apparatus> A sophisticated external beam radiotherapy machine which has the capabilities of focussing irradiation (although not very finely).
Acronym: LinAC
(16 Dec 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • contact dermatitis
    Á¢ÃË ÇǺο°
  • dermatitis
    ÇǺο°
  • linear
    ÁÙÀÇ
  • linear
    Á÷¼±ÀÇ(À¸·Î ÀÌ·ç¾îÁø);¼±ÀÇ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear measure
    ôµµ
  • linear motor
    ¼±Çü¸ðÅÍ
  • linear programming
    ¼±Çü°èȹ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á